Mitigation Strategies for Pandemic Influenza A: Balancing Conflicting Policy Objectives
暂无分享,去创建一个
T. Déirdre Hollingsworth | Roy M. Anderson | Hans Heesterbeek | Mark M. Tanaka | Don Klinkenberg | T. Hollingsworth | R. Anderson | H. Heesterbeek | D. Klinkenberg | T Dé Irdre Hollingsworth | Mark M Tanaka | T. Dé Irdre Hollingsworth
[1] Simon Cauchemez,et al. Assessing the severity of the novel influenza A/H1N1 pandemic , 2009, BMJ : British Medical Journal.
[2] Kosa Sudhorm,et al. Pandemic (H1N1) 2009 , 2009 .
[3] J. Wallinga,et al. Different Epidemic Curves for Severe Acute Respiratory Syndrome Reveal Similar Impacts of Control Measures , 2004, American journal of epidemiology.
[4] Neil M. Ferguson,et al. The effect of public health measures on the 1918 influenza pandemic in U.S. cities , 2007, Proceedings of the National Academy of Sciences.
[5] Joanna Ellis,et al. The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom. , 2009, PLoS currents.
[6] M. Lipsitch,et al. Public health interventions and epidemic intensity during the 1918 influenza pandemic , 2007, Proceedings of the National Academy of Sciences.
[7] Sally M. Blower,et al. Imperfect vaccines and herd immunity to HIV , 1993, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[8] M. Pagano,et al. Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA , 2009, Influenza and other respiratory viruses.
[9] Simon Cauchemez,et al. The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom , 2010, PLoS currents.
[10] M Elizabeth Halloran,et al. Strategy for distribution of influenza vaccine to high-risk groups and children. , 2005, American journal of epidemiology.
[11] S. Riley. Large-Scale Spatial-Transmission Models of Infectious Disease , 2007, Science.
[12] N. Arinaminpathy,et al. Antiviral treatment for the control of pandemic influenza: some logistical constraints , 2008, Journal of The Royal Society Interface.
[13] David J. Philp,et al. Quantifying social distancing arising from pandemic influenza , 2007, Journal of The Royal Society Interface.
[14] Sandra Mounier-Jack,et al. How prepared is Europe for pandemic influenza? Analysis of national plans , 2006, The Lancet.
[15] M. Safan,et al. Title Pros and cons of estimating the reproduction number from earlyepidemic growth rate of influenza A ( H 1 N 1 ) 2009 , 2010 .
[16] E. Lyons,et al. Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings , 2009, Science.
[17] A. Nizam,et al. Containing pandemic influenza with antiviral agents. , 2004, American journal of epidemiology.
[18] B. Levin,et al. Antiviral Resistance and the Control of Pandemic Influenza , 2007, PLoS medicine.
[19] Stefano Merler,et al. Age-prioritized use of antivirals during an influenza pandemic , 2009, BMC infectious diseases.
[20] T. Jefferson,et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review , 2007, BMJ : British Medical Journal.
[21] Lisa Sattenspiel,et al. Simulating the effect of quarantine on the spread of the 1918–19 flu in Central Canada , 2003, Bulletin of mathematical biology.
[22] D. Cummings,et al. Strategies for mitigating an influenza pandemic , 2006, Nature.
[23] Hiroshi Nishiura,et al. Early Epidemiological Assessment of the Virulence of Emerging Infectious Diseases: A Case Study of an Influenza Pandemic , 2009, PloS one.
[24] M. van Boven,et al. Optimizing infectious disease interventions during an emerging epidemic , 2009, Proceedings of the National Academy of Sciences.
[25] M. Postma,et al. Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs , 2009, European journal of public health.
[26] C. Fraser,et al. Factors that make an infectious disease outbreak controllable. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Jit,et al. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. , 2010, Vaccine.
[28] J Wallinga,et al. Distribution of vaccine/antivirals and the ‘least spread line’ in a stratified population , 2010, Journal of The Royal Society Interface.
[29] Marc Lipsitch,et al. Use of Cumulative Incidence of Novel Influenza A/H1N1 in Foreign Travelers to Estimate Lower Bounds on Cumulative Incidence in Mexico , 2009, PloS one.
[30] A. Flahault,et al. Estimating the impact of school closure on influenza transmission from Sentinel data , 2008, Nature.
[31] Nadav Davidovitch,et al. Cost-Benefit of Stockpiling Drugs for Influenza Pandemic , 2005, Emerging infectious diseases.
[32] Sandra Mounier-Jack,et al. Pandemic influenza: are Europe's institutions prepared? , 2006, European journal of public health.
[33] R. Anderson,et al. Potential public health impact of imperfect HIV type 1 vaccines. , 2005, The Journal of infectious diseases.
[34] M. Postma,et al. Mitigation of pandemic influenza: review of cost–effectiveness studies , 2009, Expert review of pharmacoeconomics & outcomes research.
[35] N. Ferguson,et al. Closure of schools during an influenza pandemic , 2009, The Lancet Infectious Diseases.
[36] C. Macken,et al. Mitigation strategies for pandemic influenza in the United States. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[37] Christophe Fraser,et al. The Effectiveness of Contact Tracing in Emerging Epidemics , 2006, PloS one.
[38] Laura M. Glass,et al. Targeted Social Distancing Designs for Pandemic Influenza , 2006, Emerging infectious diseases.
[39] P. Horby,et al. Nonpharmaceutical Interventions for Pandemic Influenza, National and Community Measures , 2006, Emerging infectious diseases.
[40] M. Safan,et al. Pros and cons of estimating the reproduction number from early epidemic growth rate of influenza A (H1N1) 2009 , 2010, Theoretical Biology and Medical Modelling.
[41] C. Fraser,et al. Reducing the impact of the next influenza pandemic using household-based public health interventions. , 2006, Hong Kong medical journal = Xianggang yi xue za zhi.
[42] Nilimesh Halder,et al. Analysis of the effectiveness of interventions used during the 2009 A/H1N1 influenza pandemic , 2010, BMC public health.
[43] J. Medlock,et al. Optimizing Influenza Vaccine Distribution , 2009, Science.
[44] R. May,et al. Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.
[45] Alessandro Vespignani,et al. Modeling the Worldwide Spread of Pandemic Influenza: Baseline Case and Containment Interventions , 2007, PLoS medicine.
[46] N. Ferguson,et al. Will travel restrictions control the international spread of pandemic influenza? , 2006, Nature Medicine.
[47] Marc Lipsitch,et al. Hedging against Antiviral Resistance during the Next Influenza Pandemic Using Small Stockpiles of an Alternative Chemotherapy , 2009, PLoS medicine.
[48] C. Fraser,et al. Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[49] W. Edmunds,et al. Delaying the International Spread of Pandemic Influenza , 2006, PLoS medicine.
[50] D. Cummings,et al. Strategies for containing an emerging influenza pandemic in Southeast Asia , 2005, Nature.
[51] Sandra Mounier-Jack,et al. Progress and shortcomings in European national strategic plans for pandemic influenza. , 2007, Bulletin of the World Health Organization.